Altered visual cortical function has been observed in Rett syndrome patients and in mouse models carrying mutations in MeCP2 or FOXG1, thereby supporting the notion that VEPs can serve as a dependable biomarker for assessing the pathological state of the brain [61, 62]. This evidence concerns the gene FOXG1 and Rett syndrome.